Mar 6
|
Q4 2023 Marinus Pharmaceuticals Inc Earnings Call
|
Mar 5
|
Marinus Pharmaceuticals (MRNS) Reports Q4 Loss, Lags Revenue Estimates
|
Mar 5
|
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
|
Feb 6
|
Strength Seen in Catalent (CTLT): Can Its 9.7% Jump Turn into More Strength?
|
Jan 2
|
Those who invested in Marinus Pharmaceuticals (NASDAQ:MRNS) a year ago are up 156%
|
Dec 7
|
Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
|
Jul 3
|
Strength Seen in Marinus Pharmaceuticals (MRNS): Can Its 5.4% Jump Turn into More Strength?
|
Apr 27
|
Marinus Pharmaceuticals to Provide Business Update and Report First Quarter 2023 Financial Results on May 11, 2023
|